Mead Johnson Nutrition Co.

Ichnos Glenmark Innovation (IGI) has a lot at stake as it readies to present first-time data from the Phase I study of its T cell-engaging trispecific antibody (ISB 2001) at the upcoming American Soci

Abbott continues rebounding from infant formula production problems and widespread recalls in 2022 while also facing lawsuits targeting those products in addition to multi-district litigation allegi

Abbott turned a page for its US powder infant formula business in its latest quarter and forecast more progress ahead after meeting its federal Women, Infants, and Children program order backlog and

Perrigo Company PLC makes its case for claiming hypoallergenic infant formula it provides as retailers’ store brands costs less than Mead Johnson Nutrition Co. ’s Enfamil Nutramigen brand but doesn’